Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice

Parasitology Research

Volumn 112, Issue 7, 2013, Pages 2593-2599

  Qu, Daofeng ^a   Han, Jianzhong ^a   Du, Aifang ^b  

^a ZHEJIANG GONGSHANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; CYTOKINE; DNA VACCINE; GENOMIC DNA; MULTIANTIGENIC DNA VACCINE; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXOCYTOSIS; FEMALE; IMMUNE RESPONSE; INCIDENCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTES; MICE; MICE, INBRED ICR; PROTEIN-SERINE-THREONINE KINASES; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SURVIVAL ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

MUS; TOXOPLASMA GONDII;

EID: 84879551728     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-013-3425-0     Document Type: Article

References (27)

1. Belakova J, Horynova M, Krupka M, Weigl E, Raska M (2007) DNA vaccines: are they still just a powerful tool for the future? Arch Immunol Ther Exp (Warsz) 55(6):387-398. doi: 10.1007/s00005-007-0044-4
2. Dubey JP (2010) Toxoplasma gondii infections in chickens (Gallus domesticus): prevalence, clinical disease, diagnosis and public health significance. Zoonoses Public Health 57(1):60-73. doi: 10.1111/j.1863-2378.2009. 01274.x
3. El Hajj H, Lebrun M, Arold ST, Vial H, Labesse G, Dubremetz JF (2007) ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog 3(2):e14. doi: 10.1371/journal.ppat.0030014
4. Fang R, Nie H, Wang Z, Tu P, Zhou D, Wang L, He L, Zhou Y, Zhao J (2009) Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet Parasitol 164(2-4):134-140. doi: 10.1016/j.vetpar.2009.06.012
5. Fang R, Feng H, Hu M, Khan MK, Wang L, Zhou Y, Zhao J (2012) Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Vet Parasitol 187(1-2):140-146. doi: 10.1016/j. vetpar. 2011.12.007
6. Hiszczynska-Sawicka E, Akhtar M, Kay GW, Holec-Gasior L, Bickerstaffe R, Kur J, Stankiewicz M (2010) The immune responses of sheep after DNA immunization with, Toxoplasma gondii MAG1 antigen - with and without co-expression of ovine interleukin 6. Vet Immunol Immunopathol 136(3-4):324-329. doi: 10.1016/j.vetimm.2010.03.018
7. Ismael AB, Sekkai D, Collin C, Bout D, Mevelec MN (2003) The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 71(11):6222-6228
8. Liu S, Shi L, Cheng YB, Fan GX, Ren HX, Yuan YK (2009) Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice. Parasitol Res 105(1):267-274. doi: 10.1007/s00436-009-1393-1
9. Liu MM, Yuan ZG, Peng GH, Zhou DH, He XH, Yan C, Yin CC, He Y, Lin RQ, Song HQ, Zhu XQ (2010) Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res 106(5):1079-1084. doi: 10.1007/s00436-010-1742-0
10. Mevelec MN, Bout D, Desolme B, Marchand H, Magne R, Bruneel O, Buzoni-Gatel D (2005) Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23(36):4489-4499. doi: 10.1016/j.vaccine.2005.04.025
11. Qu D, Wang S, Cai W, Du A (2008) Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vaccine 26(35):4541-4548. doi: 10.1016/j.vaccine.2008.06.030
12. Qu D, Yu H, Wang S, Cai W, Du A (2009) Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vet Parasitol 166(3-4):220-227. doi: 10.1016/j.vetpar.2009.08.016
13. Qu DF, Yu HJ, Liu Z, Zhang DF, Zhou QJ, Zhang HL, Du AF (2011) Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen. Vet Parasitol 179(1-3):28-34. doi: 10.1016/j.vetpar.2011. 02.008
14. Quan JH, Chu JQ, Ismail HA, Zhou W, Jo EK, Cha GH, Lee YH (2012) Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii. Clin Vaccine Immunol 19(5):666-674. doi: 10.1128/CVI.05385-11
15. Ramos JM, Milla A, Rodriguez JC, Padilla S, Masia M, Gutierrez F (2011) Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain. Parasitol Res 109(5):1447-1452. doi: 10.1007/s00436-011-2393-5
16. Roberts CW, Ferguson DJ, Jebbari H, Satoskar A, Bluethmann H, Alexander J (1996) Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun 64(3):897-904
17. Rosenberg C, De Craeye S, Jongert E, Gargano N, Beghetto E, Del Porto P, Vorup-Jensen T, Petersen E (2009) Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens. Vaccine 27(18):2489-2498. doi: 10.1016/j.vaccine.2009.02.058
18. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, Ajioka JW, Boothroyd JC (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314(5806):1780-1783. doi: 10.1126/science. 1133690
19. Sayles PC, Gibson GW, Johnson LL (2000) B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun 68(3):1026-1033
20. Tan F, Hu X, Luo FJ, Pan CW, Chen XG (2011) Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II. Vaccine 29(15):2742-2748. doi: 10.1016/j.vaccine.2011.01.089
21. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, Beatty WL, Hajj HE, Jerome M, Behnke MS, White M, Wootton JC, Sibley LD (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314(5806):1776-1780. doi: 10.1126/science.1133643
22. Wang H, He S, Yao Y, Cong H, Zhao H, Li T, Zhu XQ (2009) Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Exp Parasitol 122(3):226-232. doi: 10.1016/j.exppara.2009.04.002
23. Wu XN, Lin J, Lin X, Chen J, Chen ZL, Lin JY (2012) Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitol Res 111(5):2001-2009. doi: 10.1007/s00436-012-3047-y
24. Wurtz O, Bajenoff M, Guerder S (2004) IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms. Int Immunol 16(3):501-508
25. Yu L, Yamagishi J, Zhang S, Jin C, Aboge GO, Zhang H, Zhang G, Tanaka T, Fujisaki K, Nishikawa Y, Xuan X (2012) Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitol Int 61(3):481-486. doi: 10.1016/j.parint.2012.04.001
26. Zhang J, He S, Jiang H, Yang T, Cong H, Zhou H, Gu Q, Li Y, Zhao Q (2007) Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol Res 101(2):331-338. doi: 10.1007/s00436-007-0465-3
27. Zhou H, Gu Q, Zhao Q, Zhang J, Cong H, Li Y, He S (2007) Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol Res 100(4):829-835. doi: 10.1007/s00436-006-0341-6